Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice Mounjaro's appetite-reducing effects within the first one to four days of their initial injection, though the timeline varies between individuals. The medicine reaches measurable levels in the bloodstream within 24 hours of a dose and hits peak concentration at roughly 48–72 hours — which is often when appetite suppression feels strongest. That said, Mounjaro is a prescription-only treatment requiring clinical assessment before a prescriber decides whether it is right for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Within hours of your first injection, tirzepatide is already being absorbed from the subcutaneous tissue into your bloodstream. You probably won't feel much in this window, and that's normal. The 2.5mg starting dose is deliberately modest, its job is to let your body adjust, not to produce dramatic results immediately. Injection technique matters here: a clean site, rotated each week between your abdomen, thigh and upper arm, helps absorption stay consistent.
Some people do report mild nausea within a few hours of their first dose. If that happens, it's usually brief. Others feel nothing at all on day one. Neither pattern predicts how the treatment will work for you longer term.
One quick check worth building into your routine: once you've injected, note the time and the date on your phone, or on the box itself. It takes under a minute and removes any guesswork about when your next dose is due seven days later.
This is the window most people describe as the first noticeable shift. Peak plasma concentration lands around 48–72 hours after each dose, and that timing maps closely onto when the GIP and GLP-1 receptors tirzepatide activates are working hardest on the appetite and satiety signals your brain receives. You may find meals feel filling sooner, or that the urge to snack simply isn't there the way it used to be.
It doesn't feel dramatic for everyone. Some people describe it as a quiet background change, portions that used to disappear without much thought now feel like enough. Others notice it sharply. The experience after that first injection is genuinely individual, and the prescribing team at a regulated service will always explain what to watch for.
Gastrointestinal side effects (nausea, constipation, loose stools, or a sense of fullness that tips into discomfort) tend to cluster in this same 48–72-hour window. They're common and generally mild to moderate, especially at the starter dose. The full side-effect picture for Mounjaro covers what's typical versus what needs medical attention.
By your second or third injection you'll have a clearer sense of how your body is responding. The early nausea, if you had it, usually eases as you stay at 2.5mg. Your appetite-related effects may deepen slightly as tirzepatide accumulates to a steady state in the body, this takes around four weeks of weekly injections to stabilise fully, according to the NHS medicines information for tirzepatide.
Weight changes in this period are gradual. Expecting rapid week-on-week drops leads to frustration, the SURMOUNT-1 trial followed participants for 72 weeks precisely because meaningful, sustained weight reduction takes months, not days. If you're wondering what the broader weight-loss treatment landscape looks like alongside Mounjaro, that context can be useful at this stage.
One thing prescribers note: how much appetite suppression you feel at 2.5mg doesn't reliably forecast your response at higher doses. Dose increases happen in four-week steps under clinical supervision, not because a set number of weeks have passed but because the prescriber reviews how you're doing and makes an individual call. If you're weighing up the cost of ongoing treatment at this point, understanding what a legitimate private prescription includes is worth a read before you make decisions on price alone.
A pattern some people notice: appetite suppression feels stronger in the middle of the week after injection and slightly less pronounced by day six or seven, just before the next dose is due. This isn't a sign the medicine has stopped working. It reflects the natural pharmacokinetic curve, concentration rising, peaking, then gently declining over the seven-day cycle as your body processes the dose.
If this late-week dip feels significant, the right conversation is with your prescriber rather than adjusting anything yourself. The post-injection care page covers what to do (and not do) in the hours after each dose, and when side effects typically start relative to injection timing is covered in more detail separately.
What your prescriber is ultimately watching across these weeks is a combination of weight response, side-effect burden, and your overall wellbeing, the NICE appraisal of tirzepatide notes that if less than 5% weight loss has occurred after six months at the highest tolerated dose, continuing treatment should be clinically reviewed. That review framework, from NICE technology appraisal TA1026, underpins how responsible prescribers manage Mounjaro for the long term.
If you have concerns at any stage (about how you're feeling, about side effects that aren't settling, or about whether you're on the right dose) reaching our clinical team is always the right first step. And if you haven't yet had a clinical assessment, checking your eligibility with our prescribers is straightforward and free.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.